Industry ownership intelligence

Medical Instruments & Supplies insider conviction

Executive and director activity assessed across 34 companies for breadth, transaction quality, clustering, freshness, and directional conviction.

Market dashboardHealthcare sectorCompany signalsFiling ledgerData API
41/100

Distribution bias

92/100 confidence
Level
Industry
Evidence window
Latest 90 days
Named insiders
160
Latest evidence
11 Sep 2026

Capital positioning read

Distribution bias

Priced common-share disposals are concentrated enough to warrant review, but they are not treated as a standalone bearish forecast.

Demand a stronger confirmation bar

Evidence in favour

  • 36 distinct acquisition events survive duplicate and security-type controls.
  • Participation spans 160 named insiders rather than one filing source.
  • The latest qualifying evidence is fresh, dated 11 Sep 2026.

Decision risks

  • Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Conviction41Distribution bias
Confidence92Deep evidence
Controlled events190directional common-share events
Company breadth34represented companies
Acquisition value$15.0Mnormalized amount
Disposal value$68.7Mnormalized amount

Flow regime

Twelve-week filing pressure

Shows the cadence and balance of the full filing tape.

3729 Jun
1706 Jul
4113 Jul
2320 Jul
2427 Jul
4703 Aug
5610 Aug
1717 Aug
1424 Aug
9331 Aug
4007 Sep
014 Sep
AcquisitionsDisposalsScore 41 · Confidence 92

Relative positioning

Industry peer map

Current score with confidence.

Drug Manufacturers - GeneralBalanced insider tape5594 confidence Pharmaceutical RetailersNo directional read5014 confidence BiotechnologyBalanced insider tape4893 confidence Medical DevicesBalanced insider tape4792 confidence Medical Instruments & SuppliesDistribution bias4192 confidence Diagnostics & ResearchDistribution bias3696 confidence Drug Manufacturers - Specialty & GenericDistribution bias3495 confidence Medical Care FacilitiesConcentrated distribution3287 confidence Healthcare PlansConcentrated distribution3092 confidence Medical DistributionConcentrated distribution3078 confidence Health Information ServicesConcentrated distribution2893 confidence

Directional balance

Controlled event mix

18.9%acquisition
Acquisition events
36
Disposal events
154
Net value
-$53.7M

Evidence quality

What the filings represent

Common equity285
Equity compensation44
Options and derivatives42
Other securities51

Decision makers

Role participation

CEO and chair130
Other executive103
Director96
Finance leadership49
Other or unspecified41
Large holder3

Quality controls

Evidence usability

Normalized values
49%
Priced common share
48%
Named insiders
160
Controlled events
190

Auditable evidence

Latest Medical Instruments & Supplies filings

Showing 1 to 30 of 422.

ISRGIntuitive Surgical Inc
BROSIUS, MARKEVP & Chief Mfg and Supply Cha
DisposalCommon equity
$9.1KDirectional evidence
ISRGIntuitive Surgical Inc
BROSIUS, MARKEVP & Chief Mfg and Supply Cha
DisposalCommon equity
$8.0KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$283.5KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$259.5KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$161.0KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$136.9KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$127.3KDirectional evidence
PDEXPro-Dex Inc
CHARLTON, ALISHAChief Financial Officer
DisposalCommon equity
$91.6KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$71.6KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$58.8KDirectional evidence
PDEXPro-Dex Inc
CHARLTON, ALISHAChief Financial Officer
DisposalCommon equity
$49.4KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$47.3KDirectional evidence
PDEXPro-Dex Inc
VAN, KIRK RICHARD LEE JRDirector, Chief Executive Officer
DisposalCommon equity
$19.4KDirectional evidence
ISRGIntuitive Surgical Inc
BROSIUS, MARKEVP & Chief Mfg and Supply Cha
DisposalCommon equity
$8.1KDirectional evidence
RMDResMed Inc
FARRELL, MICHAEL J.Director, Chairman and CEO
DisposalOptions and derivatives
Not reportedContext evidence
TFXTeleflex Incorporated
SALMON, SEANDirector
AcquisitionOptions and derivatives
Not reportedContext evidence
TFXTeleflex Incorporated
SALMON, SEANDirector
AcquisitionCommon equity
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
FAVORITE, ANNETTE FSr. VP & Chief HR Officer
DisposalOptions and derivatives
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
FAVORITE, ANNETTE FSr. VP & Chief HR Officer
DisposalOptions and derivatives
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
FAVORITE, ANNETTE FSr. VP & Chief HR Officer
DisposalOptions and derivatives
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
LAGARDE, MICHELDirector, President and CEO
AcquisitionEquity compensation
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
LAGARDE, MICHELDirector, President and CEO
AcquisitionOptions and derivatives
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
LAGARDE, MICHELDirector, President and CEO
AcquisitionOptions and derivatives
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
LAGARDE, MICHELDirector, President and CEO
AcquisitionOptions and derivatives
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
LAGARDE, MICHELDirector, President and CEO
AcquisitionEquity compensation
Not reportedContext evidence
WSTWest Pharmaceutical Services Inc
LAGARDE, MICHELDirector, President and CEO
AcquisitionEquity compensation
Not reportedContext evidence
RMDResMed Inc
FARRELL, MICHAEL J.Director, Chairman and CEO
DisposalCommon equity
$1.1MDirectional evidence
WSTWest Pharmaceutical Services Inc
FAVORITE, ANNETTE FSr. VP & Chief HR Officer
DisposalCommon equity
$960.4KDirectional evidence
WSTWest Pharmaceutical Services Inc
FAVORITE, ANNETTE FSr. VP & Chief HR Officer
DisposalCommon equity
$960.1KDirectional evidence
WSTWest Pharmaceutical Services Inc
FAVORITE, ANNETTE FSr. VP & Chief HR Officer
DisposalCommon equity
$852.0KDirectional evidence

Group-level method

Breadth before headline value

Company breadth

A sector or industry score must be supported across companies. One very large filing cannot manufacture broad conviction.

Economic duplicates

Matching company, date, side, security class, share count, and value records are consolidated for the directional calculation.

Evidence hierarchy

Priced common-share activity determines direction. Compensation and derivative records are mapped separately so ownership mechanics remain visible.

Positioning use

The score identifies where insider alignment merits research or where disposal concentration needs review. Price, trend, valuation, and portfolio risk still decide positioning.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context